According to the International Labour Organization’s 2020 figures, every year, more than 2.78 million people die because of occupational accidents or work-related diseases, while there are some 374 million non-fatal work-related injuries.

Last November, to help companies understand vaccine efficacy and provide them with policy development guidance to achieve high rates of vaccination amongst staff, IOGP and Ipieca updated their joint position paper on COVID-19 vaccines. Five months on, we met up with Guillermo Gomez Diaz (Eni) and Hans Berg (Shell) to ask them to share their thoughts on the current state of the COVID-19 pandemic and whether vaccinations are still necessary.

In November, IOGP and IPIECA published a position paper on COVID-19 vaccines which aims to help companies understand vaccine efficacy and provides guidance for company policy development aimed at achieving high rates of vaccination amongst staff.

This document aims to provide clarity on the current types of testing, the opportunities and limitations they provide and a method to assess if testing is appropriate for a specific operational site or organization. It will be reviewed on a monthly basis, or sooner if appropriate.